Benefits
Weight management
A meta-analysis of chitosan trials found modest reductions in body weight and body fat versus control, though effects were small (about 0.8 kg) with no significant change in BMI or waist. Those trials used mostly shellfish-derived chitosan; KiOnutrime-CsG is a fungal (Aspergillus niger) chitosan that has not itself been tested in these weight trials, so the data are extrapolated to it as a member of the chitosan class.
Fat binding
Chitosan can bind some dietary fat in the gut, but the amount of extra fat excreted in human studies is small and inconsistent.
Shellfish-free option
Being fungal-derived, it suits vegetarians and people with shellfish allergies, unlike traditional shellfish chitosan.
Mechanism of action
Electrostatic fat binding
Positively charged chitosan binds negatively charged fatty acids and bile acids in the gut, forming complexes that are excreted rather than absorbed.
Bile-acid sequestration
In theory, binding bile acids could prompt the body to draw on cholesterol to replace them, but human data on chitosan and cholesterol are limited and inconsistent.
Clinical trials
Systematic review and meta-analysis of randomized controlled trials of chitosan on body weight and composition. (Huang et al. 2020, Critical Reviews in Food Science and Nutrition)
Adults across multiple RCTs of chitosan; the pooled trials used mostly shellfish-derived chitosan, not the fungal KiOnutrime-CsG form.
Chitosan supplementation supported modest reductions in body weight versus control.